Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients

Pape, 2004, Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center, Ann N Y Acad Sci, 1014, 222, 10.1196/annals.1294.025

Modlin, 2003, A 5-decade analysis of 13,715 carcinoid tumors, Cancer, 97, 934, 10.1002/cncr.11105

Rindi, 2006, TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system, Virchows Arch, 449, 395, 10.1007/s00428-006-0250-1

Panzuto, 2005, Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization, Endocr Relat Cancer, 12, 1083, 10.1677/erc.1.01017

Klőppel, 2004, The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification, Ann N Y Acad Sci, 1014, 13, 10.1196/annals.1294.002

Ferrone, 2007, Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?, J Clin Oncol, 25, 5609, 10.1200/JCO.2007.12.9809

NCI. Surveillance, Epidemiology, and End Results (SEER) Program Limited-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, based on the November 2006 submission. In. April 2007 ed; 2007.

Yu, 1999, Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome, J Clin Oncol, 17, 615, 10.1200/JCO.1999.17.2.615

Phan, 1998, Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients, J Gastrointest Surg, 2, 473, 10.1016/S1091-255X(98)80039-5

Schindl, 2000, Is the new classification of neuroendocrine pancreatic tumors of clinical help?, World J Surg, 24, 1312, 10.1007/s002680010217

Thompson, 1988, Islet cell carcinomas of the pancreas: a twenty-year experience, Surgery, 104, 1011

Kent, 1981, Nonfunctioning islet cell tumors, Ann Surg, 193, 185, 10.1097/00000658-198102000-00010

Bilimoria, 2007, Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients, J Gastrointest Surg, 11, 1460, 10.1007/s11605-007-0263-3

Bettini, 2008, Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours, Ann Oncol, 19, 903, 10.1093/annonc/mdm552

Fitzgerald T, Hickner Z, Schmitz M, Seah A, Kort E. Increasing incidence of nonfunctional neuroendocrine tumors of the pancreas. In: ASCO Gastrointestinal Cancers Symposium Orlando, Florida, 2007.

Bloomston, 2006, Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas, J Gastrointest Surg, 10, 1361, 10.1016/j.gassur.2006.09.004

Gullo, 2003, Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study, Am J Gastroenterol, 98, 2435, 10.1111/j.1572-0241.2003.07704.x

Solorzano, 2001, Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients, Surgery, 130, 1078, 10.1067/msy.2001.118367

Bilimoria, 2007, Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors, J Am Coll Surg, 205, 558, 10.1016/j.jamcollsurg.2007.05.009

Hellman, 2002, Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases, World J Surg, 26, 991, 10.1007/s00268-002-6630-z

Chamberlain, 2000, Hepatic neuroendocrine metastases: does intervention alter outcomes?, J Am Coll Surg, 190, 432, 10.1016/S1072-7515(00)00222-2

House, 2006, Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer, J Gastrointest Surg, 10, 138, 10.1016/j.gassur.2005.05.004

Musunuru, 2006, Metastatic neuroendocrine hepatic tumors: resection improves survival, Arch Surg, 141, 1000, 10.1001/archsurg.141.10.1000

Norton, 2003, Aggressive surgery for metastatic liver neuroendocrine tumors, Surgery, 134, 1057, 10.1016/j.surg.2003.07.025

Touzios, 2005, Neuroendocrine hepatic metastases: does aggressive management improve survival?, Ann Surg, 241, 776, 10.1097/01.sla.0000161981.58631.ab

Givi, 2006, Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival, Surgery, 140, 891, 10.1016/j.surg.2006.07.033

Falconi, 2008, Pancreatic insufficiency after different resections for benign tumours, Br J Surg, 95, 85, 10.1002/bjs.5652